RFT5-dgA Immunotoxin（The University Of Texas Southwestern Medical Center）

N/A

Report date: 2024/07/04 20:00:24

Base Information

Drug NameRFT5-dgA Immunotoxin（The University Of Texas Southwestern Medical Center）
Drug Alias Nameanti-CD25 immunotoxin IMTOX25（The University Of Texas Southwestern Medical Center）
ClassificationBiologics > Protein drugs > Toxin
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity of Texas Southwestern Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity of Texas Southwestern Medical Center
Active IndicationsN/A
Inactive IndicationsLymphoma

Other Information

ATC CodeN/A
Related LinksN/A